although antigenic modulation inhibits the potential therapeutic effectiveness of unconjugated t101 antibody in cll patients , treatment of cll with t101 drug or toxin immunoconjugates under conditions that bring about rapid and extensive internalization of the t65 antigen may provide an effective means of therapy .
C0003241
antibody
C0243020
immunoconjugates